CL2004001603A1 - USE OF GABAXADOL TO PREPARE A USEFUL MEDICATION FOR THE TREATMENT OF NEUROPATHIC PAIN. - Google Patents

USE OF GABAXADOL TO PREPARE A USEFUL MEDICATION FOR THE TREATMENT OF NEUROPATHIC PAIN.

Info

Publication number
CL2004001603A1
CL2004001603A1 CL200401603A CL2004001603A CL2004001603A1 CL 2004001603 A1 CL2004001603 A1 CL 2004001603A1 CL 200401603 A CL200401603 A CL 200401603A CL 2004001603 A CL2004001603 A CL 2004001603A CL 2004001603 A1 CL2004001603 A1 CL 2004001603A1
Authority
CL
Chile
Prior art keywords
gabaxadol
prepare
treatment
neuropathic pain
useful medication
Prior art date
Application number
CL200401603A
Other languages
Spanish (es)
Inventor
Bjarke Sanchez Connie Ebert
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36701616&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2004001603(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of CL2004001603A1 publication Critical patent/CL2004001603A1/en

Links

CL200401603A 2003-06-25 2004-06-24 USE OF GABAXADOL TO PREPARE A USEFUL MEDICATION FOR THE TREATMENT OF NEUROPATHIC PAIN. CL2004001603A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200300956 2003-06-25

Publications (1)

Publication Number Publication Date
CL2004001603A1 true CL2004001603A1 (en) 2005-05-27

Family

ID=36701616

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200401603A CL2004001603A1 (en) 2003-06-25 2004-06-24 USE OF GABAXADOL TO PREPARE A USEFUL MEDICATION FOR THE TREATMENT OF NEUROPATHIC PAIN.

Country Status (4)

Country Link
CN (2) CN101156850A (en)
CL (1) CL2004001603A1 (en)
UA (1) UA90656C2 (en)
ZA (1) ZA200509356B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105816457A (en) * 2016-05-30 2016-08-03 杨强 Pharmaceutical composition containing paroxetine hydrochloride and application of pharmaceutical composition
US20180338959A1 (en) * 2017-05-24 2018-11-29 Ovid Therapeutics Inc. Treatment of depressive disorders
KR20210039324A (en) * 2018-04-06 2021-04-09 오비드 테라퓨틱스 인크. The use of gaboxadol in the treatment of substance use disorders
EP3883566A4 (en) 2018-11-21 2022-09-07 Certego Therapeutics Inc. Gaboxadol for reducing risk of suicide and rapid relief of depression
MX2022014599A (en) 2020-05-20 2022-12-16 Certego Therapeutics Inc Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders.

Also Published As

Publication number Publication date
CN101156850A (en) 2008-04-09
UA90656C2 (en) 2010-05-25
ZA200509356B (en) 2007-03-28
CN1809350A (en) 2006-07-26

Similar Documents

Publication Publication Date Title
IS8142A (en) Medication useful for the treatment of pain
AR059390A1 (en) USE OF FLIBANSERINE FOR THE TREATMENT OF PREMENOPAUSIC SEXUAL DESIRE DISORDERS
CL2004001069A1 (en) COMPOUNDS DERIVED FROM 1-BENZOIL-ISOQUINOLINAS SUBSTITUTED; PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OR PROFILAXIS OF TYPE II DIABETES.
CL2016000117A1 (en) Autotaxin inhibitors comprise a heteroaromatic ring-benzylamine basic cycle
CL2008000691A1 (en) COMPOUNDS DERIVED FROM DIHIDRO AND TETRAHIDRO OXAZOLOPIRIMIDINONAS REPLACED; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF CHICHOPHRENIA, EPILEPSY, BETWEEN OTHER DISEASES.
CL2007001918A1 (en) SUBSTITUTED HETEROARILY DERIVATIVE COMPOUNDS; METHOD FOR THE PREPARATION OF COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, DEPRESSION, ALZHEIMER'S DISEASE AND HYPERTENSION BETWEEN OTHERS.
CL2008001994A1 (en) COMPOUNDS DERIVED FROM PIRAZIN-2-ONA; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, ATEROSCLEROSIS, HYPERTENSION, AMONG OTHERS.
CY1112320T1 (en) TAPENDADOL TITLE
IL174823A0 (en) Medical injection device monutable to the skin
CL2007003643A1 (en) PHARMACEUTICAL COMPOSITION OF AZIMILIDINE THAT INCLUDES 0.5% TO APPROXIMATELY 2.5% (W / W) OF WATER; AND USE FOR THE TREATMENT OF CARDIAC ARRITMIAS.
CL2012001290A1 (en) Compounds derived from arylated camphenes, selective stimulants of cb2 receptors; Preparation process; pharmaceutical composition; and its use for the treatment of a selected disease, disorder or condition of inflammation, pain, allergy, diabetes, atherosclerosis, arthritis and emesis, among others.
BRPI0409359A (en) somatostatin-dopamine chimeric analogs
ITRM20030204A0 (en) DERMATOLOGICAL FORMULATION.
PA8806501A1 (en) TRIAZOLOTRIAZINAS AND TRIAZOLOPIRAZINAS AND ITS USE
CL2004001421A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMPOUND DERIVED FROM 1,4-DIPIPERIDIN-4-IL-PIPERAZINA; AND ITS USE FOR THE PREVENTION AND / OR TREATMENT OF PAIN.
CL2004001603A1 (en) USE OF GABAXADOL TO PREPARE A USEFUL MEDICATION FOR THE TREATMENT OF NEUROPATHIC PAIN.
CL2008000965A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN OPIACEAL ANALGESIC, AND ITS USE FOR PAIN TREATMENT.
DE50304722D1 (en) Fungicidal drug combinations
DK1732487T3 (en) Medical patch for application to the skin
CL2004001607A1 (en) USE OF GABAXAFOL TO PREPARE A USEFUL MEDICINAL PRODUCT IN THE TREATMENT OF DEPRESSION.
ITBO20030521A1 (en) ENDOSCOPE FOR OCULISTIC USE.
RU2003110288A (en) ANTI-PRESSIVE SUBSTANCE
CL2004000487A1 (en) USE OF R (+) - ALPHA- (2,3-DIMETOXIFENIL) -1- [2- (4-FLUOROPHENYL) ETHYL] -4-PIPERIDINMETHANOL OR A SALT OF THE SAME TO PREPARE A USEFUL MEDICATION TO TREAT THE SOIL DISORDER.
PE20080455A1 (en) MIRTAZAPINE FOR THE TREATMENT OF NEUROPATHIC PAIN
CL2007003395A1 (en) USE OF AGOMELATIN FOR THE OBTAINING OF DRUGS INTENDED FOR THE TREATMENT OF PERIVENTRICULAR LEUCOMALACY.